Redcare Pharmacy N.V.
LEI 529900JK6UXHY1YKZ082Netherlandsfmd_1PANQMCM8QECBA1B9WRD1XKSGNTemplate: Standard
This company files annual reports on an EU or UK regulated market, not with the SEC. Statements come from its ESEF annual report in EUR and are not converted. Ownership, prices, dividends and events are built from SEC and US market data and are not available for it.
Coverage: Dec 31, 2023 to Dec 31, 2025, 2 periods
| Line item | FY2024 |
|---|---|
| Total revenues | 2,371 |
| Cost of revenue | 1,825 |
| Gross profit | 546 |
| Operating income | (39) |
| Interest expense | 17 |
| Income before taxes | (48) |
| Income tax expense | (2) |
| Net income from continuing operations | (46) |
| Net income | (46) |